Untitled

Abstract

There is a misconception among transplant clinicians that contraception after a successful renal transplant is challenging. This is partly due to the complex nature of transplant patients, where immunosuppression and graft dysfunction create major concerns. In addition, good evidence regarding contraception and transplant is scarce, with most of the evidence extrapolated from observational and case-controlled studies, thus adding to the dilemma of treating these patients. In this review, we closely analyzed the different methods of contraception and critically evaluated the efficacy of the different options for contraception after kidney transplant. We conclude that contraception after renal transplant is successful with acceptable risk. A multidisciplinary team approach involving obstetricians and transplant clinicians to decide the appropriate timing for conception is recommended. Early counseling on contraception is important to reduce the risk of unplanned pregnancies, improve pregnancy outcomes, and reduce maternal complications in patients after kidney transplant. To ascertain appropriate advice on the method of contraception, individualizing the method of contraception according to a patient's individual risks and expectations is essential.

Hormonal intrauterine device in women with renal transplantation: a prospective observational study

“…Renal transplant recipients should be counseled to use safe and highly effective methods, including long-acting reversible contraception: hormonal intrauterine device (levonorgestrel), non-hormonal intrauterine device (copper), and subdermal implant 9 , 13 - 15 . Although there is consensus on the need for appropriate contraceptive methods in solid organ transplant recipients, there is less evidence to support their efficacy and safety 9 , 14 - 16 .…”